Stockreport

Rain Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference

Rain Oncology Inc.  (RAIN) 
PDF NEWARK, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN) (“Rain”), a late-stage company developing precision oncology therapeutics, t [Read more]